Citations

Showing 10 of 108119 citations.

A retrospective antibiotic prescribing assessment and examination of potential antibiotic stewardship targets in patients with COVID-19
Stevens, Ryan W. , Kooda, Kirstin , Mara, Kristin C. , Shah, Aditya , Kooda, Kirstin , Mara, Kristin, Shah, Aditya S , Mara, Kristin C , Stevens, Ryan W , Jensen, Kelsey , O’Horo, John C.

Mayo Clinic

JAC-Antimicrobial Resistance | October 22, 2021 | Volume: 3 | Issue: 4 | Pages: No page available

10.1093/jacamr/dlab170 | PMID 34755114 Get It

Abstract Objectives Despite low rates of bacterial coinfection in patients admitted with COVID-19, antimicrobials are frequently prescribed. Our primary objective was to evaluate antimicrobial prescribing over time in patients admitted with COVID-19. The secondary objectives were to evaluate the role of ID providers in antimicrobial utilization, describe the rate of confirmed bacterial infection and determine factors associated with empirical antimicrobial prescribing in COVID-19. Materials and methods Retrospective review was performed for adult patients admitted to a tertiary care centre with COVID-19 between 1 March 2020 and 30 November 2020. Patient demographics, disease severity, risk factors for severe disease, clinical outcomes, antimicrobial prescribing and respiratory microbiological testing were collected and analysed. Prescribing trends were evaluated by month, and factors contributing to prescribing were established using univariate and multivariable analysis. Results Antibiotics were prescribed during admission in 37.9% of the study cohort, with 85.1% of patients who received antibiotics having therapy initiated within 48 h of admission. Antibiotic prescribing incidence increased with disease. Over the study period, antimicrobial prescribing rates decreased by 8.7% per month. Multivariable analysis found ICU admission, obtainment of procalcitonin values, intubation, heart failure, haemodialysis and nursing home residence were associated with empirical antimicrobial prescribing. Conclusions Unnecessary antimicrobial prescribing in patients with viral syndromes like COVID-19 continues to represent an area of concern. Antimicrobial stewardship efforts during COVID-19 should consider patient-specific factors associated with antibiotic prescribing. Recognition of such factors, in combination with application of well-established antimicrobial stewardship tactics, may serve to impact antimicrobial prescribing trends, even as patient volumes rise.
A Small Molecule Exploits Hidden Structural Features within the RNA Repeat Expansion That Causes c9ALS/FTD and Rescues Pathological Hallmarks
Ursu, Andrei , Baisden, Jared T. , Bush, Jessica A. , Taghavi, Amirhossein , Zhang, Yong‐Jie , Petrucelli, Leonard , Yildirim, Ilyas , Disney, Matthew D. , Yildirim, Ilyas , Disney, Matthew D , Zhang, Yong-Jie , Choudhary, Shruti , Gendron, Tania F.

Mayo Clinic

ACS Chemical Neuroscience | October 22, 2021 | Volume: 12 | Issue: 21 | Pages: 4076-4089

10.1021/acschemneuro.1c00470 | PMID 34677935 Get It

Towards Causal Analysis of Genetic Factors for Colorectal Cancer
Miller, David C. , Lawrence, Andrew D. , Miller, David, Chockler, Hana , McNamee, Daniel , Chia, Nicholas

Mayo Clinic

No container title available | October 22, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-967255/v1 Get It

Abstract We present preliminary results and outline future work for the causal analysis of genetic factors influencing the occurrence and severity of colorectal cancer. The findings are based on publicly available datasets. We show that using relatively simple methods we are able to detect meaningful dependencies, reflecting the current biomedical knowledge about the causes of cancer and related conditions (such as infection and sepsis). We also argue that a deeper analysis, taking into account gene regulation, would require a significantly larger dataset.
Chaos in the Brickyard
Forscher, Bernard K.

Mayo Clinic

Science | October 22, 2021 | Volume: 142 | Issue: 3590 | Pages: 339-339

10.1126/science.142.3590.339.a Get It

Real-world Cardiovascular Outcomes Associated With Degarelix vs Leuprolide for Prostate Cancer Treatment
Wallach, Joshua D. , Deng, Yihong , Dhruva, Sanket S. , Berkowitz, Alyssa, Quinto, Kenneth , Gandotra, Charu , Crown, William H. , Shah, Nilay D. , Lyon, Timothy D. , Yao, Xiaoxi , Wallach, Joshua D , Lyon, Timothy D , Deng, Yihong , McCoy, Rozalina G. , Herrin, Jeph , Polley, Eric C. , Noseworthy, Peter A. , Ross, Joseph S.

Mayo Clinic

JAMA Network Open | October 22, 2021 | Volume: 4 | Issue: 10 | Pages: e2130587

10.1001/jamanetworkopen.2021.30587 | PMID 34677594 Get It

Nazi Persecution of Scientists
Alvarez, Walter C.

Mayo Clinic

Science | October 22, 2021 | Volume: 109 | Issue: 2823 | Pages: 122-122

10.1126/science.109.2823.122.b Get It

Hiding in (not so) plain sight: Spontaneous tumor Lysis syndrome due to intravascular large B cell lymphoma
Ho, Matthew , Zanwar, Saurabh , Habermann, Thomas M. , Navin, Patrick J. , Salama, Mohamed E. , Parikh, Sameer A. , Duggan, Patrick, Carr, Ryan, Habermann, Thomas , Parikh, Sameer A , Navin, Patrick , Ho, Matthew , Duggan, Patrick, Carr, Ryan M

Mayo Clinic

American Journal of Hematology | October 22, 2021 | Volume: 97 | Issue: 1 | Pages: 151-159

10.1002/ajh.26383 | PMID 34677833 Get It

Coronavirus disease 2019 (Covid‐19) vaccination recommendations in special populations and patients with existing comorbidities
Afshar, Zeinab Mohseni , Janbakhsh, Alireza , Mansouri, Feizollah , Sio, Terence T. , Sullman, Mark J. M. , Carson‐Chahhoud, Kristin , Hosseinzadeh, Rezvan , Barary, Mohammad , Ebrahimpour, Soheil , Mohseni Afshar, Zeinab , Babazadeh, Arefeh , Janbakhsh, Alireza , Mansouri, Feizollah , Sio, Terence T , Sullman, Mark J M , Carson-Chahhoud, Kristin , Hosseinzadeh, Rezvan , Barary, Mohammad , Ebrahimpour, Soheil

Mayo Clinic

Reviews in Medical Virology | October 22, 2021 | Volume: 32 | Issue: 3 | Pages: No page available

10.1002/rmv.2309 | PMID 34677889 Get It

SummaryVaccination against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is a crucial step in ending the current worldwide pandemic. However, several particularly vulnerable groups in the population were not included in sufficient numbers in coronavirus disease 2019 (Covid‐19) vaccine trials. Therefore, as science advances, the advice for vaccinating these special populations against Covid‐19 will continue to evolve. This focused review provides the latest recommendations and considerations for these special populations (i.e., patients with rheumatologic and autoimmune disorders, cancer, transplant recipients, chronic liver diseases, end‐stage renal disease, neurologic disorders, psychiatric disorders, diabetes mellitus, obesity, cardiovascular diseases, chronic obstructive pulmonary disease, human immunodeficiency virus, current smokers, pregnant and breastfeeding women, the elderly, children, and patients with allergic reactions) using the currently available research evidence.
Antibiosis: The Future of Antibiotherapy and Antibiotic Research . Papers from a conference, Paris, Feb. 1980. L. Ninet, P. E. Bost, D. H. Bouanchaud, And J. Florent, Eds. Academic Press, New York, 1981. xx, 508 pp., illus. $
Washington, John A.

Mayo Clinic

Science | October 22, 2021 | Volume: 215 | Issue: 4539 | Pages: 1496-1497

10.1126/science.215.4539.1496.b Get It

Feeding the Kidney Researcher Pipeline through R25-NIDDK Funded Summer Undergraduate Research Fellowships: A Student Perspective
Wilson, Elena , Lipp, Sarah N. , Brady, Clayton , Ishibe, Shuta , Romero, Michael F. , Wilson, Elena M , Brady, Clayton T , Romero, Michael F

Mayo Clinic

Kidney360 | October 22, 2021 | Volume: 3 | Issue: 3 | Pages: 546-549

10.34067/kid.0001272021 | PMID 35582187 Get It